SG Americas Securities LLC boosted its position in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) by 594.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,509 shares of the company's stock after buying an additional 92,880 shares during the period. SG Americas Securities LLC owned 0.06% of Envista worth $1,873,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in the company. Franklin Resources Inc. raised its position in shares of Envista by 72.6% in the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock valued at $132,223,000 after buying an additional 2,882,844 shares during the last quarter. Brickwood Asset Management LLP purchased a new stake in Envista during the 4th quarter valued at about $40,037,000. Norges Bank purchased a new stake in Envista during the 4th quarter valued at about $38,052,000. Dimensional Fund Advisors LP raised its holdings in Envista by 19.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,762,091 shares of the company's stock valued at $130,440,000 after acquiring an additional 1,089,923 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C lifted its stake in Envista by 4,949.9% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,018,415 shares of the company's stock worth $19,645,000 after purchasing an additional 998,248 shares in the last quarter.
Envista Trading Up 1.0%
Shares of NYSE NVST traded up $0.19 during mid-day trading on Thursday, reaching $18.62. 1,604,863 shares of the company's stock were exchanged, compared to its average volume of 2,552,332. The company's 50-day moving average is $17.26 and its 200-day moving average is $18.52. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.82 and a current ratio of 2.12. The firm has a market capitalization of $3.16 billion, a price-to-earnings ratio of -2.85, a PEG ratio of 1.17 and a beta of 0.99. Envista Holdings Corporation has a 52-week low of $14.22 and a 52-week high of $23.00.
Envista (NYSE:NVST - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.04. Envista had a negative net margin of 44.90% and a positive return on equity of 4.07%. The company had revenue of $616.90 million during the quarter, compared to analyst estimates of $608.17 million. During the same quarter last year, the firm posted $0.26 earnings per share. Envista's revenue was down 1.1% compared to the same quarter last year. Analysts expect that Envista Holdings Corporation will post 1 EPS for the current fiscal year.
Analyst Ratings Changes
NVST has been the topic of several recent research reports. Robert W. Baird upgraded Envista from a "neutral" rating to an "outperform" rating and boosted their target price for the stock from $21.00 to $23.00 in a report on Tuesday, May 27th. Wells Fargo & Company set a $19.00 price objective on Envista in a research report on Saturday, March 8th. UBS Group lowered their price objective on Envista from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. JPMorgan Chase & Co. cut their target price on Envista from $20.00 to $19.00 and set a "neutral" rating for the company in a research note on Thursday, March 6th. Finally, Baird R W upgraded Envista from a "hold" rating to a "strong-buy" rating in a report on Tuesday, May 27th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $20.23.
Check Out Our Latest Stock Analysis on NVST
Envista Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
